Visiting IBD Fellow Program

Our Visiting IBD Fellow program accepts qualified gastroenterology 2nd & 3rd year** fellows for a one-month, (most) expenses-paid observation at a leading IBD center. This highly competitive fellow program offers you exposure in treating and managing IBD patients.

By participating, you will:

  • Improve your IBD skills by following a standard curriculum designed by expert faculty with real-world experience.
  • Be exposed to clinical practices employed at leading IBD Centers.
  • Share evidence-based and expert opinion-based approaches to the diagnosis, treatment, and management of IBD.

Download the current curriculum by clicking link - CCFA Visiting IBD Fellowsip Curriculum

Downolad the current reading list by clicking link - CCFA Professional Education Reading List 2015

Programs are held at these CCFA IBD Visiting Fellow Centers * throughout the country:

*CCFA IBD VIsiting Fellow Centers are subject to change.

**Are you an advanced fellow and want to learn more about other advanced fellowship training opportunities?  Download the attached listing of programs in the United States: Advanced Fellowship Opportunities

Interested in becoming a CCFA IBD Visiting Fellow Center?  We welcome interested IBD centers to apply to become a host institution for the Visiting IBD Fellowship  program. Please note that we have already secured for the 2015-2016 cycle and are not currently anticipating  expanding the program due to the limited number of fellows supported through the program, but we welcome your institution to apply and your application will be kept on file for future consideration.

Program Details

The Visiting IBD Fellow program is designed for 2nd and 3rd year gastrointestinal (GI) fellows who express an interest in learning more about IBD—irrespective of their plans to be in private practice or stay in academics. Ideally, the program targets GI fellows who are at centers that do not have IBD-specific curricula or a sufficient volume of patients for training.  .

This highly-competitive program has limited space and is open to GI Fellows interested in either adult or pediatric IBD. The Crohn's & Colitis Foundation of America will pay some of your program-related expenses, including travel and accommodations. The 2015-2016 program is supported by an educational grant from AbbVie Inc. and  Janssen Services, LLC.

Participant selection criteria include the following:

  • Candidates must be enrolled in an accredited fellowship training program within the U.S. at the time of application and at the time of scheduled rotation.
  • Candidates employed by a participating host institution may apply and will be reviewed on a case-by-case basis, but candidates from other programs will receive priority.
  • Candidates should express a specific interest in IBD education for a future career (not necessarily IBD specialty or academics).
  • Candidates should have the full support of their program director for time away from the candidate's home institution for the duration of the program.

The Visiting IBD Fellows represent the best and brightest applicants from the gastroenterology fellow community.
Congratulations to the selected physicians  and their home institutions for the:

2015-2016  Visiting IBD Fellowship Program

Visiting IBD Fellow Home Institution Hosting Physician CCFA IBD Visiting Fellow Centers
Dr. Adam Tritsch SAUSHEC Dr. Stephen Hanauer Northwestern University
Dr. Arathi Lakhole Children's Hospital- Los Angeles Dr. Marla Dubinsky Mount Sinai Medical Center
Dr. Brian Hanson University of Minnesota Dr. David Rubin University of Chicago
Dr. Eric Mao Brown University Dr. Vijay Yanik Massachusetts General Hospital
Dr. Farah Monzur Stony Brook University Dr. Thomas Ullman Mount Sinai Medical Center
Dr.Karin Gilkison SAUSHEC Dr. Darrell Pardi Mayo Clinic
Dr.Kinjal Suryawala Oklahoma University, The Children's Hospital Dr. David Rubin University of Chicago
Dr.Margaret Adamcewicz University of Rochester Medical Center Dr. Miguel Regueiro University of Pittsburgh
Dr. Michael Sherman Naval Nedical Center San Diego Dr. Darrell Pardi Mayo Clinic
Dr. Michelle Vu University of California, Los Angeles Dr. Thomas Ullman Mount Sinai Medical Center
Dr. Ojasvini Choudhry University of Nebraska Medical Center Dr. Sherwin Rabizadeh Cedar Sinai Medical Center
Dr. Pavan Mankal St. Lukes &  Roosevelt Hospitals Dr. Thomas Ullman
Mount Sinai Medical Center
Dr. Piyali Sengupta University of Texas HSC at Houston Dr. Marla Dubinsky Mount Sinai Medical Center
Dr. Poonam Beniwal-Patel University of Wisconsin-Madison Hospitals & Clinics Dr.David Rubin University of Chicago
Dr. Robert Hirten North Shore- Long Island Jewish Medical Center Dr. Thomas Ullman Mount Sinai Medical Center
Dr. Rubin Bahuva University at Buffalo, SUNY Dr. Bo Shen Cleveland Clinic Foundation
Dr. Sean Fine Brown University Dr. Uma Mahadevan University of California at San Francisco
Dr. Shannon Chang New York University Dr.Stephen Hanauer Northwestern University

Comments :

"This experience was invaluable in helping me observe practice styles and management algorithms outside my own institution. Many of the "pearls" I learned in the approach to the IBD patient will be incorporated in how I practice medicine."

"This fellowship increased my fund of knowledge about IBD, gave me more confidence in treating difficult to manage IBD patients, and taught me how to manage treatment failures. The CCFA rotation is honestly one of my favorite experiences that I have ever had in my medical career so far. I came away with so many lessons about IBD, research, and how to manage a great IBD practice with an excellent collaborative team approach."

"The experience at thehost institution will prove invaluable to my future practice. I feel much more comfortable with managing difficult patients with refractory IBD and I now  have experience with newer medications and managing techniques."

"I had a very positive experience and learned a lot about both new therapies for IBD, new techniques in endoscopy, and surgical management of patient's with IBD. I was able to witness chromoendoscopy which I found to be a beneficial technique I'd like to bring to my home institution. I also was able to use therapies such as  natalizumab, tacrolimus, and cyclosporine which I had not used previously for IBD."

The  2016-2017 program year  is now closed.*

 * Applicatons  for the 2016-2017 year are no longer being accepted. The 2016-2017 program year runs from July 1, 2016 to June 30, 2017. This activity is supported by educational grants from AbbVie, Janssen Services, LLC, and Takeda Pharmaceuticals U.S.A., Inc.  If you have any questions, please email Anzee Sherap at